Mettler-Toledo Release: Live Webinar On Safe And Cost-Effective Capsule Filling

Greifensee, Switzerland. Dec 1, 2014 – Mettler Toledo has announced an upcoming live webinar entitled “Safe and cost-effective capsule filling for pre-clinical and first-in-man studies,” featuring guest presenter Matthew Greene from CoreRx, Inc. This webinar will be presented on December 15, 2014 at 11:00 EST (15:00 GMT). Filling capsules is a very common activity in pre-clinical and first-in-man studies, but how this is carried out typically depends on the throughput required and the resources available.

This 60-minute webinar describes solutions that neatly fill the gap between manual filling methods and costly high-throughput systems. These solutions have proved to be up to five times faster than manual dosing, whilst being a fraction of the cost and size of automated filling machines.

During the webinar, attendees will learn more about cost-effective solutions for filling capsules in small-batches (10’s – 1000’s); understand how to fill individual weights of API in capsule or dose API/excipient blends without segregation using automation; and discover how to optimize process safety with an integrated capsule filling workflow. This webinar will be hosted by Pharmaceutical Technology on December 15, 2014 at 11:00 EST (16:00 GMT). Register for the live webinar at: www.tinyurl.com/MTcapsuleweb

About METTLER TOLEDO

METTLER TOLEDO provides the enabling technology, software and people that can help build a seamless workflow to translate bench scale chemistry into a commercial process. For more than 20 years, our enabling tools and services have been a strategic resource providing critical information for thousands of development scientists and engineers. Companies have used that knowledge to accelerate the discovery, development and scale-up of new chemical processes spanning the chemical and biopharmaceutical industries. For more, visit Mettler Toledo website

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC